Reported 2 days ago
Thermo Fisher Scientific Inc. (NYSE:TMO) has received FDA approval for its Oncomine Dx Express Test, designed for the Ion Torrent Genexus Dx Integrated Sequencer. This test serves as both an in vitro diagnostic and a companion diagnostic for Dizal’s ZEGFROVY, a targeted therapy for non-small cell lung cancer patients with specific mutations. Capable of detecting mutations across 46 genes, this rapid next-generation sequencing technology can provide vital genomic results in as little as 24 hours, enhancing timely cancer treatment opportunities.
Source: YAHOO
Reported 2 days ago
Motorola Solutions, Inc. has unveiled the Cubi NUC AI+ 2MG, a mini PC measuring just 0.826 liters but equipped with advanced AI capabilities powered by a Neural Processing Unit. This device supports features like live captions with translation, creative cocreation tools, and quick information recall, all while emphasizing security through fingerprint recognition and dual high-speed LAN ports. Motorola believes this product sets a new standard for mini computing.
Source: YAHOO
Reported 2 days ago
Alcon Inc. has received approval for the Clareon PanOptix Pro intraocular lens in Canada, featuring advanced ENLIGHTEN NXT Optical technology that maximizes light utilization to 94%. This innovative lens also enhances light distribution and contrast between distance and intermediate vision. It is expected to be available in Canada by early 2026 through a preloaded delivery system.
Source: YAHOO
Reported 2 days ago
Barclays has maintained a Hold rating on ONEOK, Inc. (NYSE:OKE) with a price target of $91 following the company's fiscal Q1 2025 earnings report, which showed a net income increase to $691 million but missed EPS estimates. Despite the setback from sold pipeline assets, ONEOK saw year-over-year growth in natural gas volumes, particularly in the Rocky Mountain region, prompting management to reaffirm their full-year guidance for 2025.
Source: YAHOO
Reported 2 days ago
Merck & Co., Inc. (NYSE: MRK) has announced that the Advisory Committee on Immunization Practices has approved ENFLONSIA, a new treatment aimed at preventing respiratory syncytial virus in infants under 8 months. This approval comes after favorable results from clinical trials, demonstrating significant reductions in RSV-related medical issues. The final approval is pending from the CDC Director or the Health and Human Services Secretary.
Source: YAHOO
Reported 2 days ago
Wells Fargo analyst Stephen Baxter has maintained a Buy rating for Elevance Health, Inc. (NYSE:ELV), with a price target of $478, following the company's strong performance in Q1 2025 that surpassed expectations with $48.8 billion in revenue and an EPS of $11.97. The growth is attributed to an increase in Medical Members and targeted expansion in Medicare Advantage, although a slowdown in Individual ACA memberships is anticipated for Q2.
Source: YAHOO
Reported 2 days ago
Diageo plc has finalized the sale of its 54.4% stake in Seychelles Breweries Limited to Phoenix Beverages Limited for about $80 million. This strategic move, announced on July 1, 2025, allows Diageo to focus more on its portfolio management while still maintaining its key brands, such as Guinness and Smirnoff RTDs, through new licensing agreements in the region.
Source: YAHOO
Reported 2 days ago
JPMorgan has reduced its price target for Copart, Inc. (CPRT) from $60 to $55, maintaining a Neutral rating following the company’s fiscal Q3 2025 results. Despite a year-over-year revenue increase of 7.49% to $1.21 billion, Copart fell short of revenue expectations by $17.1 million, although EPS of $0.42 met market predictions. The firm indicated challenges in the market contributed to these results, especially noting stagnation in US segment sales.
Source: YAHOO
Reported 2 days ago
J.P. Morgan has reiterated a Buy rating for Schlumberger Limited (SLB), maintaining a price target of $44. Analyst Arun Jayaram highlighted the company's operational stability despite challenges in well construction, expecting flat revenue and margins in 2025. Schlumberger is also expanding into digital and low-carbon solutions, which should drive growth in non-oil and gas sectors. The company is projected to generate approximately $4 billion in free cash flow in 2025, allowing for significant returns to shareholders through dividends and buybacks.
Source: YAHOO
Reported 2 days ago
Wells Fargo has reaffirmed a Buy rating for Thermo Fisher Scientific (TMO), setting a price target of $570. Analyst Brandon Couillard highlighted a recent amendment to the acquisition of Solventum Corp that simplifies the deal and potentially accelerates its closure by the end of 2025. The agreement excludes Solventum's lower-margin Drinking Water Filtration business, which aligns with Thermo Fisher's focus on higher-margin sectors. The revision is expected to positively impact TMO's earnings, which is forecasting strong organic growth of 7% to 9% in the long-term.
Source: YAHOO
Reported 2 days ago
Sanofi's Riliprubart has been awarded orphan drug designation in Japan for treating chronic inflammatory demyelinating polyneuropathy (CIDP). This monoclonal antibody specifically targets activated C1s in the immune response, addressing a significant unmet medical need as around 30% of CIDP patients do not adequately respond to current treatments. Further studies are ongoing to assess Riliprubart's efficacy and safety, marking a key milestone for Sanofi in its pediatric treatment efforts.
Source: YAHOO
Reported 2 days ago
As U.S. President Trump's tariff deadline approaches, global investors remain largely unfazed and expect manageable outcomes, believing these scenarios are already reflected in market prices. While the potential for increased tariffs has caused fluctuations, many investors have adjusted their expectations and see the market as resilient, despite some setbacks in trade negotiations. The ongoing discussions in Congress regarding tax changes also create a backdrop of uncertainty, yet stock markets are experiencing gains.
Source: YAHOO
Reported 2 days ago
Source: BARRONS
Reported 2 days ago
Investment firm Azoria Partners has decided to delay the launch of its Azoria Tesla Convexity exchange traded fund, originally scheduled for next week, following Elon Musk's announcement of forming a new political party in the U.S. Azoria CEO James Fishback expressed concerns about Musk's political ambitions potentially conflicting with his role at Tesla and voiced support for President Donald Trump, prompting the postponement.
Source: YAHOO
Reported 2 days ago
Source: BARRONS
Reported 2 days ago
Drive Capital, a Columbus-based venture firm, has recently achieved significant success by returning $500 million to investors in just one week, following internal challenges including a co-founder split that threatened its stability. The firm's strategy emphasizes investments in companies producing substantial liquidity events outside Silicon Valley’s ultra-competitive environment, focusing on traditional industries such as healthcare and data storage. While the firm has seen both significant successes and notable failures, it remains well positioned with a unique investment approach that has garnered attention and support from notable tech billionaires.
Source: YAHOO
Reported 2 days ago
Source: INVESTORS
Reported 3 days ago
Source: WSJ
Reported 3 days ago
Source: WSJ
Reported 3 days ago
Source: WSJ
Reported 3 days ago
The account known as The Louvre of Bluesky has vanished, leaving many users nostalgic for its sharp commentary and humorous captures of bizarre posts on the platform. Known for highlighting the absurdities of social media, this account served as both entertainment and a cautionary reminder of how easily one can post something regrettable. The account's creator has mentioned that the hiatus is temporary, attributed to external pressures, but the uncertainty of its return leaves followers hoping it will rise again to continue its legacy.
Source: YAHOO
Reported 3 days ago
Canada is considering financial support for major aluminum producers like Rio Tinto if the U.S. maintains its 50% tariffs on aluminum imports. The CEO of the Aluminium Association of Canada indicated that early discussions are underway, especially as the tariffs could significantly impact the financial stability of the sector. These talks come amidst broader negotiations with the U.S. to address trade concerns, following the cancellation of a digital services tax aimed at American tech companies.
Source: YAHOO
Reported 3 days ago
As Donald Trump's deadline for trade deals looms, the world economy faces uncertainty after three months of fluctuating tariffs. With the end of the 90-day reprieve approaching, the U.S. president plans to reinstate tariffs aimed at reducing trade deficits and revitalizing American manufacturing. This shift may generate revenue for the Treasury and impact inflation, job growth, and investment, while raising concerns for various sectors reliant on trade.
Source: YAHOO
Reported 3 days ago
In July, small carriers faced a challenging market marked by volatile rates and rising diesel costs, prompting some to make smart strategic moves while others struggled. Successful carriers focused on local routes, strengthened relationships during downtime, prioritized driver coaching, monitored costs closely, and embraced technology to improve operations. Conversely, many failed to plan for profitability, neglected safety protocols, missed opportunities for direct business contacts, and let emotions dictate their rate decisions. As carriers prepare for August, they are encouraged to learn from July's lessons to enhance their strategies and operations.
Source: YAHOO